Sunday, December 28, 2025
Sunday, December 28, 2025

A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to results of a Phase III trial.

A team of researchers has developed a software tool that provides a way for the safer design of genome editing in all organisms with a transcriptome. For about a decade, researchers have used the CRISPR technology for genome editing. However, there are some challenges in the use of CRISPR. The new analysis system overcomes these challenges and allows researchers to perform safer on- and off-target assessments without a reference genome. It holds the potential for applications in medicine, agriculture, and biological research.

More Articles …

  1. Clock change 'disorientating' for people with dementia - charity
  2. Biggest cervical cancer drug advance in 20 years hailed
  3. Welsh Ambulance Service declares extraordinary incident due to delays
  4. Rebecca Adlington reveals miscarriage heartbreak
  5. TikTok personal trainer says stammer is his superpower
  6. Mental health help for under-fives overlooked - report
Page 1796 of 1938